These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9065202)

  • 1. Antiretroviral therapy for pregnant women.
    Minkoff H; Augenbraun M
    Am J Obstet Gynecol; 1997 Feb; 176(2):478-89. PubMed ID: 9065202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiretroviral treatment in human immunodeficiency virus infection].
    Blum L; Bachmeyer C
    Ann Dermatol Venereol; 1997; 124(9):641-54. PubMed ID: 9739932
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretrovirals.
    Temesgen Z; Wright AJ
    Mayo Clin Proc; 1999 Dec; 74(12):1284-301. PubMed ID: 10593358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for HIV infection.
    Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928
    [No Abstract]   [Full Text] [Related]  

  • 5. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
    Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral chemotherapy.
    Saag MS; Schooley RT
    Curr Clin Top Infect Dis; 1998; 18():154-79. PubMed ID: 9779354
    [No Abstract]   [Full Text] [Related]  

  • 7. A patient's guide to protease inhibitors.
    Elperin A; Sax P
    AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome.
    Clarke SM; Mulcahy F; Healy CM; Condon S; Butler KM
    Int J STD AIDS; 2000 Apr; 11(4):220-3. PubMed ID: 10772084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial and peroxisomal dysfunction following perinatal exposure to antiretroviral drugs.
    Stojanov S; Wintergerst U; Belohradsky BH; Rolinski B
    AIDS; 2000 Jul; 14(11):1669. PubMed ID: 10983660
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and safety of saquinavir/ritonavir in HIV-infected pregnant women: INEMA cohort.
    Brunet C; Reliquet V; Jovelin T; Venisse N; Winer N; Bui E; Le Moal G; Perfezou P; De Saint Martin L; Raffi F
    Med Mal Infect; 2012 Sep; 42(9):421-8. PubMed ID: 22938775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children.
    El Beitune P; Duarte G; Quintana SM; Figueiró-Filho EA; Marcolin AC; Abduch R
    Braz J Infect Dis; 2004 Apr; 8(2):140-50. PubMed ID: 15361992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy.
    Papp E; Balogun K; Banko N; Mohammadi H; Loutfy M; Yudin MH; Shah R; MacGillivray J; Murphy KE; Walmsley SL; Silverman M; Serghides L
    J Infect Dis; 2016 May; 213(10):1532-40. PubMed ID: 26740274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of antiretrovirals in pregnant women.
    Mirochnick M; Capparelli E
    Clin Pharmacokinet; 2004; 43(15):1071-87. PubMed ID: 15568888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
    Lallemand F; Adda N; Schneider V; Jacomet C; Salhi Y; Rozenbaum W
    Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672
    [No Abstract]   [Full Text] [Related]  

  • 18. Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.
    Spooner KM; Lane HC; Masur H
    Clin Infect Dis; 1996 Jul; 23(1):15-27. PubMed ID: 8816123
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral therapy for adults and children.
    AIDS Inst Newsl; 1995 Jun; ():1-19. PubMed ID: 11367409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.